Pale Fire Capital SE’s OnKure Therapeutics OKUR Stock Holding History
Bought
Maintained
Sold
Other funds holding OKUR
NMC
TCM
HCM
CG
RVM
OCA
BCM
ACM
Pale Fire Capital SE's OKUR Position: Q1 2024 in Review
Pale Fire Capital SE sold out of OnKure Therapeutics (OKUR) in Q1 2024, closing a stake of 3,010 shares — an estimated $48.2K sold.
Pale Fire Capital SE first reported a position in OKUR in Q3 2023 and held it in 2 quarters. The position peaked at $113K in Q3 2023. 61 funds tracked by Wall St. Rank hold OKUR as of Q1 2024.
- Pale Fire Capital SE reported no remaining OnKure Therapeutics position as of Q1 2024 after selling out during the quarter.
- Pale Fire Capital SE sold 3,010 OnKure Therapeutics shares in Q1 2024, an estimated $48.2K.
- Pale Fire Capital SE first reported a position in OnKure Therapeutics in Q3 2023 and held it in 2 quarters.
- Pale Fire Capital SE's OnKure Therapeutics position peaked at $113K in Q3 2023.
- 61 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2024.
Based on Pale Fire Capital SE's 13F filing for Q1 2024, filed 14 May 2024.